major的例句大全

Multiple Regression Analysis of Liver Pathology and Other Factors in Children with β Thalassemia Major

重型β珠蛋白生成障碍性贫血肝脏病理与相关因素的多重回归分析

Genetic Study on 27 Children with β-thalassemia Major and Their Parents in Sichuan Area

四川地区重型β-地中海贫血患儿及双亲基因突变的研究

Objective To reduce the birth rate of β-thalassemia major and improve the quality of population.

目的减少β-地中海贫血重症患儿的出生。

Treatment of thalassemia major with unrelated donor bone marrow transplantation

非血缘相关骨髓移植治疗重型地中海贫血的临床研究

A pair of twin girls suffered from thalassemia major.

一对孪生姐妹婴儿患上了重型地中海贫血。

Objective To reduce the birthrate of β-thalassemia major and improve the quality of population.

目的为了降低β地中海贫血重症患儿的出生率，达到优生的目的。

Conclusion The results showed that Allo PBSCT was successful in treating β thalassemia major.

结论异基因外周血造血干细胞移植治疗重型β地贫患儿已获得成功。

Change of Serum Ferritin Level in Hyper Transfusion Thalassemia Major Children Treated by Different Dosage of Iron Chelator

不同剂量铁螯合剂治疗高量输血重型β珠蛋白生成障碍贫血患儿血清铁蛋白的变化

Most of dual gene mutations were thalassemia major, but also observed in a few of thalassemia minor cases.

β地贫基因突变以点突变为主，双重基因突变子多为重型β地贫，亦见于少数轻型β地贫。

Prophylaxis of Transplantation-related Complications after Allogeneic Stem Cell Transplantation in β-thalassemia Major

儿童重型β-地中海贫血异基因造血干细胞移植后并发症的防治

Transplantation with Combination of Umbilical Cord Blood and Neonatal Peripheral Blood in the Treatment of A Patient with β-thalassemia Major

脐带血、新生儿外周血混合移植治疗1例重型β-地中海贫血

Meta-analysis of the efficacy and safety of combined therapy with deferiprone and deferoxamine in thalassemia major patients

去铁酮和去铁胺治疗珠蛋白生成障碍性贫血临床疗效及安全性的Meta分析

Prenatal diagnosis was carried out by the mentioned techniques above for fetuses who were in the risk of thalassemia major. 5.

将上述方法运用于重型地中海贫血高风险胎儿的产前诊断中。

Twelve ( 8 males and 4 females) patients with β-thalassemia major received the hematological stem cell transplantation ( HSCT).

12例接受造血干细胞移植治疗的重型β地中海贫血患儿，年龄从25岁～115岁，男8例，女4例。

Conclusions It suggests that the PCR-RDB assay is effective in preventing the birth of β-thalassemia major and has clinical significance in improving the population quality.

结论PCR-RDB技术可有效减少β地中海贫血重症患儿的出生，具有重要的优生学意义。

Objective To investigate the change of serum ferritin ( SF) level in hyper transfusion thalassemia major ( TM) children treated with different dosage of iron chelator.

目的探讨采用不同剂量铁螯合剂治疗高量输血重型β珠蛋白生成障碍贫血（地贫）患儿1年后的血清铁蛋白（SF）的变化。

Applying the methods mentioned to diagnose the fetuses who are in the risk of thalassemia major in prenatal diagnosis can prevent the births of these babies. 3.

上述技术可应用于对重型地贫高风险胎儿的产前诊断，有效预防重型地中海贫血患儿出生。

α-Thalassemia major is a hereditary disease with a syndrome of hemolytic anemia, often caused bv the complete or partial deletion of a-globin genes.

α-地中海贫血是由于α-珠蛋白基因全部和部分缺失所致的一种遗传性溶血性贫血综合征。

The purpose of this study was to designed to analyze and explore the diagnosis and treatment on a patient with β-thalassemia major accompanied with intestinal acute graft-versus-host disease ( aGVHD) grade ⅳ after allo-peripheral blood stem cell transplantation ( allo-PBSCT).

对1例异基因外周血干细胞移植（allo PBSCT）治疗重型β地中海贫血（TM）患儿合并Ⅳ度肠道aGVHD的诊断和治疗进行分析和探讨。

In 30 cases of thalassemia minor, there were 28 cases of gene mutation heterozygotes, 2 cases of which were dual gene mutations, and 5 cases of thalassemia major were all dual gene mutations.

30例轻型β地贫中，28例为基因突变杂合子，2例是双重基因突变子；5例重型β地贫中，均为基因双重突变子。